Symbol Lookup

Thursday October 02, 2014 4:22 AM ET. Data delayed 15 minutes.
8.10
0.00 (0.00%)
Bid/Lots
0.00/0
Ask/Lots
9.97/5
Open/Prev Close
0.00/8.10
Day Range
-----
52-Week Range
7.81-23.25
Vol/Avg Daily Vol
0.0/128.9K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Cara Therapeutics to Sponsor Symposium at American Academy of Pain Management 2014 Annual Clinical Meeting
9:28AM ET on Wednesday Sep 17, 2014 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced it is sponsoring and participating in a lunch symposium titled, "Kappa: Myths / misconceptions, and moving beyond Mu," at the 25 Annual Clinical Meeting of the American Academy of Pain Management. Leading pain experts will discuss the evolving medical and regulatory climate around mu-opioids and how kappa agonists may become an important treatment option. Experts will also discuss the Phase 2 data from Cara's clinical program of CR845, a peripherally acting kappa receptor agonist for acute pain, as well as the future of analgesia.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced it is sp...

Peers Headlines

Yesterday

NeoStem Establishes Melanoma Scientific Advisory Board to Support Anticipated Phase 3 Trial
18 hours ago by GlobeNewswire
Companies Mentioned: NBS

NeoStem, Inc. ("NeoStem" or the "Company," Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today its establishment of a melanoma scientific advisory board consisting of internationally renowned experts in oncology and...

Neostem Appoints Scientific Advisory Board For Melanoma Treatment Research
20 hours ago by Midnight Trader
Companies Mentioned: NBS
07:38 AM EDT, 10/01/2014 (MT Newswires) -- Neostem (NBS) said it has put together a melanoma scientific advisory board to help it design and carry out its upcoming Intus Phase 3 clinical trial to evaluate the use of its DC/TC technology in patien...

Sep 29, 2014

NeoStem Secures $20 Mln Debt Facility to Support Intus Phase 3 Trial in Metastatic Melanoma
7:42AM ET on Monday Sep 29, 2014 by Midnight Trader
Companies Mentioned: NBS
07:42 AM EDT, 09/29/2014 (MT Newswires) -- NeoStem (NBS) Monday said it has secured a debt facility in the amount of up to $20 million, which will support its launch of its Intus Phase 3 clinical trial in metastatic melanoma. The loan and securit...
NeoStem Secures Debt Facility
7:30AM ET on Monday Sep 29, 2014 by GlobeNewswire
Companies Mentioned: NBS

Company Provides Update on Remaining Milestones for 2014

NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that it has entered into a Loan and Security Agreement ...

Sep 23, 2014

Eagle Pharmaceuticals to Present at 21st Annual NewsMakers in the Biotechnology Industry Investment Conference
10:41AM ET on Tuesday Sep 23, 2014 by Business Wire
Companies Mentioned: EGRX

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, will present at the 21st Annual BioCentury NewsMakers Conference as follows:

Sep 22, 2014

Closing Update: Stocks Have Worst Day in Seven Weeks After Chinese Official Warns New Stimulus Unlikely
4:12PM ET on Monday Sep 22, 2014 by Midnight Trader
Companies Mentioned: VIAS, MKGAF, SIAL, THLD, TTMI, CNET, CYTR
04:12 PM EDT, 09/22/2014 (MT Newswires) -- Worries over the pace of growth in the Chinese economy had investors selling stocks Monday, sending all of the major market indices to the worst declines in seven weeks Monday. Nine of the 10 industry se...
Sector Update: Health Care Stocks Ending Moderately Lower; Cytori Cutting Jobs, Takes $500,000 Restructuring Charge
4:04PM ET on Monday Sep 22, 2014 by Midnight Trader
Companies Mentioned: LCI, CYTX, THLD
04:04 PM EDT, 09/22/2014 (MT Newswires) -- Top Healthcare Stocks JNJ -0.10% PFE -0.64% ABT -0.41% MRK +0.17% AMGN -1.27% Healthcare stocks were mostly lower in afternoon trading with the NYSE Healthcare Sector Index declining around 0.4% and...
Sector Update: Health Care
4:04PM ET on Monday Sep 22, 2014 by Midnight Trader
Companies Mentioned: LCI, CYTX, THLD
04:04 PM EDT, 09/22/2014 (MT Newswires) -- Healthcare stocks were mostly lower in afternoon trading with the NYSE Healthcare Sector Index declining around 0.4% and shares of healthcare companies in the S&P 500 dropping about 0.6% as a group. In c...
Sector Update: Health Care Stocks Dropping; Early Progenic Gains Slip Away Despite Data Supporting More Testing of Cancer Drug
1:48PM ET on Monday Sep 22, 2014 by Midnight Trader
Companies Mentioned: LCI, PGNX, THLD
01:48 PM EDT, 09/22/2014 (MT Newswires) -- Top Healthcare Stocks JNJ -0.19% PFE -1.15% ABT -0.73% MRK +0.21% AMGN -1.93% Health care stocks were mostly lower in afternoon trading, with the NYSE Health Care Sector Index declining around 0.6% ...
Sector Update: Health Care
1:38PM ET on Monday Sep 22, 2014 by Midnight Trader
Companies Mentioned: LCI, PGNX, THLD
01:38 PM EDT, 09/22/2014 (MT Newswires) -- Health care stocks were mostly lower in afternoon trading, with the NYSE Health care Sector Index declining around 0.6% and shares of health care companies in the S&P 500 dropping about 0.8% as a group. ...
← Newer123Older →